Complete title: ALTE11C2, Health Effects after Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy
Research Study Number | ALTE11C2 |
Principal Investigator | Eric Chow, MD |
Phase | N/A |
Other eligibility criteria may apply.
Research Study Number | ALTE11C2 |
Contact | Claire Wharton |
Telephone | 206/884-4494 |
Keywords: Hematologic Malignancies; Lymphoma, Hodgkin; Leukemia; Lymphoma; Lymphoproliferative Disorders; Pediatric Cancers, Miscellaneous; Neoplasms; Leukemia, Lymphoid; Immunoproliferative Disorders; Cardiovascular Diseases; Leukemia, T-Cell; Immune System Diseases; Cardiomyopathies
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.